We have located links that may give you full text access.
CLINICAL TRIAL
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Hemostasis during MARS therapy and hemodiafitration in patiens with acute renal-hepatic failure].
Anesteziologiia i Reanimatologiia 2012 May
OBJECTIVE: to study the dynamics of the haemostatic system, depending on coagulopathy type and efferent therapy method (HDF, MARS) in patiens with acute renal-hepatic failure. As a complex of intensive therapy, all the patients were trated extracorporeal techniques: HDF therapy in group I (n = 121) and MARS in group 1 (n = 62). Patients were aged from 18 to 67 years.
RESULTS AND DISCUSSION: MARS - is an effective therapy and has effects on haemostasis system: observed recovery of platelet-vascular disorders of coagulation and haemostasis. HDF is effective in patients with coagulation type of laboratory disseminated intravascular coagulation (DIC), and was dangerous in fibrinolytic DIC type because of haemostasis status decompensation risk.
RESULTS AND DISCUSSION: MARS - is an effective therapy and has effects on haemostasis system: observed recovery of platelet-vascular disorders of coagulation and haemostasis. HDF is effective in patients with coagulation type of laboratory disseminated intravascular coagulation (DIC), and was dangerous in fibrinolytic DIC type because of haemostasis status decompensation risk.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app